Explore peer-reviewed studies on antimicrobial resistance, sterilization protocols, and outbreak management
Exploring non-anti-TNF biologics as salvage therapy for refractory acute severe ulcerative colitis, including vedolizumab, ustekinumab, and novel small molecule therapies.